Concepedia

Sunita Malkani

SM

7

Publications

338

Citations

7

H-Index

1998

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Delaware

Sunita Malkani is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1998–2016

7

Publications

7

Specific induction of early growth response gene 1 in the lateral nucleus of the amygdala following contextual fear conditioning in rats

Sunita Malkani, Jeffrey B. Rosen · Neuroscience · 2000 · 119 citations

, , +13

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.

Toyoaki Hida, Julius Leyton, Makheja An et al. · PubMed · 1998 · 105 citations

, , +17

N-Methyl-d-aspartate receptor antagonism blocks contextual fear conditioning and differentially regulates early growth response-1 messenger RNA expression in the amygdala: implications for a functional amygdaloid circuit of fear

Sunita Malkani, Jeffrey B. Rosen · Neuroscience · 2001 · 44 citations

, , +8

Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus

Jiayi Xu, Songnian Lin, Robert W. Myers et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 26 citations · Full text

, , +5

Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas as potent inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2)

Songnian Lin, Matthew Lombardo, Sunita Malkani et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 21 citations · Full text

, , +8

Rows per page

1–5 of 7